Riamilovir

• CAT Number: I035568
• CAS Number: 123606-06-4
• Molecular Formula: C5H4N6O3S
• Molecular Weight: 228.19
• Purity: 98%
• Synonyms: Riamilovir; Triazavirin; TZV
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 7-(methylsulfanyl)-3-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-4(1H)-one
• InChI: InChI=1S/C5H4N6O3S/c1-15-5-6-4-8-7-2(11(13)14)3(12)10(4)9-5/h1H3,(H,6,8,9)
• InChIKey: IDVQGNMSSHPZSJ-UHFFFAOYSA-N
• SMILES: O=C1N2C(NN=C1[N+]([O-])=O)=NC(SC)=N2

Riamilovir(CAT: I035568) is a potent antiviral agent that targets viral replication and assembly processes, demonstrating broad-spectrum efficacy against RNA viruses. Its mechanism involves modulating host immune responses and disrupting viral protein synthesis, making it effective in combating influenza, coronaviruses, and other respiratory pathogens. Riamilovir’s ability to inhibit viral replication at multiple stages supports its application in infectious disease research, particularly in studying host-pathogen interactions, antiviral resistance, and immune system modulation. This compound is instrumental in the development of therapeutic strategies aimed at treating emerging viral infections and reducing the burden of respiratory illnesses.